Twitter   LinkedInFacebookRSS  
Podcasts

Dissecting Liquid Biopsy in MBC: CTCs, ctDNA and CAMLs to Evaluate Innate Immunity
Massimo Cristofanilli, MD, FACP, Professor, Medicine; Associate Director, Translational Research and Precision Medicine; Director, OncoSET Precision Medicine Program, Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University

Last Mile of Molecular Diagnostics in Precision Medicine and Healthcare
Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates

Rapid Fire: Getting to Know Suman Bose
Suman Bose, PhD, Postdoctoral Fellow, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Looking at the Value of NGS-based Diagnostic Testing for Lung Cancer Patients
Daryl Pritchard, PhD, Professor, Bioengineering, University of Washington

Developing Low Cost Diagnostics for Infectious Disease – Strategies and Advice
Paul Yager, PhD, Professor, Bioengineering, University of Washington

Genome Sequencing Clinical Applications: What Will it Take to Make NGS Standard of Care?
Liz Worthey, Ph.D., Faculty Investigator, Director, Software Development and Informatics, HudsonAlpha Institute for Biotechnology

Reimbursement of Companion Diagnostics: Discussions for Precision Medicine
Omar Perez, Ph.D., RAC, Director and Diagnostics Lead, Oncology Programs, Worldwide R&D, Pfizer Inc.
Sponsored by Next-Generation Diagnostics Summit

Walking Down Evidence Street™: Where the Market Meets Evidence
Suzanne Belinson, Ph.D., Executive Director of Clinical Markets, Blue Cross Blue Shield Association
Sponsored by Next-Generation Diagnostics Summit  

Preview of the PanelDiscussion on IMPLEMENTATION OF MOLECULAR TESTING: Demonstrating ClinicalUtility and Measuring Health Outcomes 
Panel of speakers moderated by Julie Lynch, Ph.D., featuring Michael Kelly, M.D., Vickie L. Venne, Donna Polizio and John W. Hanna
Sponsored by Next-Generation Diagnostics Summit

RevolutionaryPoint-of-Care (POC) Diagnostic Technologies to Improve the Prevention, Controland Treatment of Infectious Diseases 
Michel G. Bergeron, O.Q., M.D., FRCPC, Director and Founder, Centre de Recherche en Infectiologie de l’Université Laval
Sponsored by Next-Generation Diagnostics Summit

POC: The Search forthe Holy Grail Continues 
Harry Glorikian, Founder and Managing Partner, Scientia Advisors LLC
Sponsored by Next-Generation Diagnostics Summit